Leyden Labs raised €40M in a funding round in Jun 2026. The company is based in Amsterdam, Netherlands. Investors in the round: ClavystBio, European Innovation Council (EIC) Fund, Gates Foundation Strategic Investment Fund and 1 other. Data as of 27 Sept 2026.
Reported in EUR — no conversion. €40M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
